1
项与 MLM-CAR44.1 T-cell therapy(MolMed) 相关的临床试验A Phase I-IIa Trial to Assess the Safety and Antitumor Activity of Autologous CD44v6 CAR T-cells in Acute Myeloid Leukemia and Multiple Myeloma Expressing CD44v6
The purpose of this first-in-man Phase I-IIa study is to evaluate the safety and antitumor activity of autologous CD44v6 CAR T-cells in patients with acute myeloid leukemia (AML) and multiple myeloma (MM).
100 项与 MLM-CAR44.1 T-cell therapy(MolMed) 相关的临床结果
100 项与 MLM-CAR44.1 T-cell therapy(MolMed) 相关的转化医学
100 项与 MLM-CAR44.1 T-cell therapy(MolMed) 相关的专利(医药)
100 项与 MLM-CAR44.1 T-cell therapy(MolMed) 相关的药物交易